SMOKING-ATTRIBUTABLE BURDEN OF FOUR TOBACCO-RELATED DISEASES IN COLOMBIA IN 2007

Author(s)

Javier Narváez, MD, MPH, Researcher/lecturer1, Nelson Alvis, Dr, Professor2, Fernando de La Hoz, MD, MSc, PhD, Associate Professor1, Julio Orozco, MD, MSc, Technical Manager3, Alexandra Porras, MD, MSc, Researcher11Universidad Nacional de Colombia, Bogotá D.C, Colombia; 2 Universidad de Cartagena, Cartagena, Colombia; 3 AYGES Consultoría S.A, Cartagena, Colombia

OBJECTIVES Estimating disease burden for lung cancer, chronic obstructive pulmonary disease (COPD), coronary heart disease (CHD) and stroke in the adult Colombian population during 2007, and the smoking-attributable fraction of such burden. METHODS A systematic review was done to identify the incidence, prevalence and mortality of the studied diseases in Colombia. This was complemented with other sources of information, such as the Colombian statistical administrative department (DANE) and International Agency for Research on Cancer (IARC) databases. DisMod-II software was used to verify and integrate the obtained estimators. These estimators were used to calculate the number of years of life lost (YLL). Similar review procedures were used to estimate smoking prevalence by gender and age group. A set of relative risks for the four diseases according to smoking status and age group was used to estimate the smoking-attributable burden. Relative risks were taken from the BENESCO (Benefits of Smoking Cessation on Outcomes) model. RESULTS Total burden for lung cancer in 2007 was estimated in 34,593 YLL, 127,982 YLL for COPD, 390,260 YLL for CHD and 161,715 YLL for stroke. The four diseases cause 714,550 YLL each year, taking the smoker and non-smoker populations as a whole. Considering that about 20% of the adult Colombians smoke, after 20 years this group would have accumulated 661,825 YLL directly attributable to smoking; these YLL could have been avoided in a hypothetical situation in which smoking habit is completely eliminated. CONCLUSIONS The smoking-attributable burden represents only a fraction of the total burden for these diseases; nevertheless, such percentage is important because it is at least partially preventable. With just 25% of smokers making an attempt to quit using the best available therapy in Colombia (varenicline efficacy after one year: 22.4%), then more than 4,600 deaths and 27,000 YLLs could be avoided by the end of the 20 years' horizon.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PRS45

Topic

Real World Data & Information Systems

Topic Subcategory

Health & Insurance Records Systems

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×